Localization of 20-kD homologous restriction factor (HRF20) in diseased human glomeruli. An immunofluorescence study
Open Access
- 1 May 1991
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 84 (2) , 256-262
- https://doi.org/10.1111/j.1365-2249.1991.tb08158.x
Abstract
SUMMARY: The 20-kD homologous restriction factor (HRF20), which is identical to CD59, is a membrane-associated protein which inhibits the reaction of C9 to form membrane attack complex (MAC) of homologous complements. In various human glomerular diseases deposition of complement components is frequently seen and MAC is reported to associate with immune deposits. Using a specific monoclonal antibody, 1F5, against HRF20, we attempted to study the localization of HRF20 in human glomerulonephritides and to compare the localization of HRF20 with those of immune deposits and MAC. The frozen sections of kidney specimens were fixed in acetone at room temperature before staining. In normal kidneys and kidney specimens from the patients with minimal change nephrotic syndrome, membranous nephropathy. and IgA nephropathy. HRF20 was strongly localized in the peritubular capillaries and along Bowman’s capsules. A weaker but well-defined staining was obtained in the mesangial area and faint staining was seen along the glomerular capillary walls. In contrast, glomerular capillary walls were rather strongly stained in the cases with diffuse lupus nephritis which had subendothelial dense deposits. These data suggest that HRF20 (CD59) is present in the human glomeruli and its expression is enhanced under certain conditions such as lupus nephritis.Keywords
This publication has 39 references indexed in Scilit:
- CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.The Journal of Experimental Medicine, 1989
- 20 KDa homologous restriction factor of complement resembles T cell activating proteinBiochemical and Biophysical Research Communications, 1989
- Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.Journal of Clinical Investigation, 1989
- A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complementInternational Immunology, 1989
- Radioimmunoassay of the Attack Complex of Complement in Serum from Patients with Systemic Lupus ErythematosusNew England Journal of Medicine, 1985
- Role of terminal complement pathway in the heterologous phase of antiglomerular basement membrane nephritisKidney International, 1985
- Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.The Journal of Experimental Medicine, 1984
- Retardation of fading and enhancement of intensity of immunofluorescence by p-phenylenediamine.Journal of Histochemistry & Cytochemistry, 1983
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- Inhibition of complement by a substance isolated from human erythrocytes—II: Studies on the site and mechanism of actionImmunochemistry, 1969